Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Chemotherapy and Bevacizumab in Stage IB-III NSCLC
NCT00960297Phase 2Terminated
- Sponsor
- SCRI Development Innovations
- Start
- Aug 2009
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by SCRI Development Innovations. Started Aug 2009; status: terminated.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00960297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00960297.